NAMS fund manager activity
NewAmsterdam Pharma Company N.V · Nasdaq. Reported by 5 tracked fund managers in their 13F filings, Q4 2022 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | New | 9,000 | $305,010 | 0.00% | Aug 14, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | No change | 3,070,146 | $104,047,000 | 2.39% | Aug 14, 2026 |
| Lee Ainslie - Maverick Capital | Added | 3,267,802 | $110,745,810 | 1.00% | Aug 14, 2026 |
| Viking Global Investors | No change | 4,203,567 | $142,458,886 | 0.41% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Stanley Druckenmiller - Duquesne Family Office | No change | 3,070,146 | $98,275,000 | 3.35% | May 15, 2026 |
| Lee Ainslie - Maverick Capital | Added | 2,186,402 | $69,986,728 | 0.81% | May 15, 2026 |
| Polen Capital Management | Sold out | — | — | 0.00% | May 14, 2026 |
| Viking Global Investors | No change | 4,203,567 | $134,556,180 | 0.38% | May 15, 2026 |
Older quarters